How can gene therapy platforms be scaled up to treat thousands of rare diseases?

Asher Mullard
Nature Reviews Drug Discovery · Springer Nature · 2026-11-13 · DOI: 10.1038/d41573-026-00179-2

Аннотация

Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.

Читать у издателя →

Похожие статьи